News

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.
By Stephanie Brown HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...
Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...
Neurizon Therapeutics has announced progress to lift a US Food and Drug Administration (FDA) clinical hold on its lead drug .
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...
Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...
The U.S. Food and Drug Administration updated its blood donation guidelines. Now, it goes off individual risk assessment ...